Smithbridge Asset Management Inc. DE held its position in shares of Varian Medical Systems Inc. (NYSE:VAR) during the third quarter, Holdings Channel reports. The fund owned 31,800 shares of the company’s stock at the end of the third quarter. Varian Medical Systems makes up about 2.8% of Smithbridge Asset Management Inc. DE’s investment portfolio, making the stock its 13th largest position. Smithbridge Asset Management Inc. DE’s holdings in Varian Medical Systems were worth $3,165,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Global X Management Co. LLC boosted its stake in shares of Varian Medical Systems by 143.0% in the second quarter. Global X Management Co. LLC now owns 1,662 shares of the company’s stock worth $137,000 after buying an additional 978 shares in the last quarter. Pacer Advisors Inc. boosted its stake in shares of Varian Medical Systems by 8.7% in the second quarter. Pacer Advisors Inc. now owns 1,780 shares of the company’s stock worth $146,000 after buying an additional 143 shares in the last quarter. Advisor Group Inc. purchased a new stake in shares of Varian Medical Systems during the second quarter worth approximately $146,000. Terra Nova Asset Management LLC purchased a new stake in shares of Varian Medical Systems during the third quarter worth approximately $208,000. Finally, Private Trust Co. NA purchased a new stake in shares of Varian Medical Systems during the third quarter worth approximately $209,000. Hedge funds and other institutional investors own 99.83% of the company’s stock.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Varian Medical Systems Inc. (NYSE:VAR) traded up 0.31% during trading on Tuesday, reaching $91.36. The company had a trading volume of 520,549 shares. The stock has a market capitalization of $8.53 billion, a price-to-earnings ratio of 21.80 and a beta of 0.67. The firm has a 50-day moving average of $92.39 and a 200-day moving average of $90.54. Varian Medical Systems Inc. has a 1-year low of $73.18 and a 1-year high of $106.70.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, October 26th. The company reported $1.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.04. The company had revenue of $912 million for the quarter, compared to analyst estimates of $880.29 million. Varian Medical Systems had a return on equity of 26.57% and a net margin of 12.51%. The business’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same quarter last year, the company posted $1.04 earnings per share. On average, analysts anticipate that Varian Medical Systems Inc. will post $4.93 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Daily Political and is the propert of of Daily Political. If you are reading this report on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The correct version of this report can be accessed at http://www.dailypolitical.com/2016/11/29/varian-medical-systems-inc-var-position-maintained-by-smithbridge-asset-management-inc-de.html.

VAR has been the subject of a number of research reports. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a research report on Monday, October 31st. Jefferies Group reaffirmed a “buy” rating and set a $98.00 price target on shares of Varian Medical Systems in a research report on Wednesday, September 28th. Zacks Investment Research cut Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Tuesday, October 25th. Finally, Robert W. Baird lifted their price target on Varian Medical Systems from $91.00 to $99.00 and gave the stock a “neutral” rating in a research report on Wednesday, September 28th. One analyst has rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $93.38.

In other Varian Medical Systems news, insider Dow R. Wilson sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $96.08, for a total transaction of $960,800.00. Following the transaction, the insider now owns 70,598 shares of the company’s stock, valued at $6,783,055.84. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Elisha W. Finney sold 2,000 shares of the firm’s stock in a transaction dated Thursday, September 1st. The stock was sold at an average price of $95.82, for a total value of $191,640.00. Following the transaction, the chief financial officer now directly owns 7,195 shares in the company, valued at approximately $689,424.90. The disclosure for this sale can be found here. Company insiders own 0.86% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection.

5 Day Chart for NYSE:VAR

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems Inc. (NYSE:VAR).

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.